NCT06577909 Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy Status RECRUITING Phase PHASE2
NCT06566989 A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008) Status COMPLETED Phase PHASE1
NCT06563245 Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Status RECRUITING Phase PHASE2/PHASE3
NCT06554639 A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) Status COMPLETED Phase PHASE1
NCT06533098 A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Status RECRUITING Phase PHASE3
NCT06527690 Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT06516978 A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06500247 Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. Status NOT_YET_RECRUITING Phase PHASE2
NCT06498089 A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis Status RECRUITING Phase PHASE4
NCT06474481 Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06474273 TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients Status RECRUITING Phase PHASE3
NCT06470243 Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body Status RECRUITING Phase PHASE3
NCT06468943 Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06452537 Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06441097 Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06425302 A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06392841 Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations Status WITHDRAWN Phase PHASE2
NCT06387121 Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL Status RECRUITING Phase PHASE2